CSF3 and Decreased total leukocyte count: The risk of G-CSF treatment generally administered for management of severe leukopenia in the acute group was 8.0 per 1000 person-years (0.2% during the first 72 days) and that in the late onset group was 0.7 per 1000 person-years.